Diagnostic test at 4–12 weeks pp (total n = 967)a and number of GI at 4–12 weeks pp | Prevalence of GI at 4–12 weeks pp (GI)b | Diagnostic test at 1-year pp | Prevalence of GI at 1-year pp (GI)b | Diagnostic test at 3-year pp | Prevalence of GI at 3-year pp (still GI)b |
---|---|---|---|---|---|
Glucose-intolerant participants at 4–12 weeks postpartum who remained glucose-intolerant at 1- year and 3-year postpartum | |||||
 oGTT (n = 176) | 18.2% | FPG & HbA1c | 74.5% | FPG & HbA1c | 66.7% |
 FPG & HbA1c (n = 266) | 27.5% | FPG & HbA1c | 62.2% | FPG & HbA1c | 50.0% |
 FPG alone (n = 127)  oGTT & HbA1c (n = 296) | 13.2% 30.7% | FPG & HbA1c FPG & HbA1c | 80.6% 60.5% | FPG & HbA1c FPG & HbA1c | 75.0% 47.6% |
Diagnostic test at 4–12 weeks pp (total n = 967)a and number of NGT at 4–12 weeks pp | Prevalence of NGT at 4–12 weeks pp (normal) | Diagnostic test at 1-year pp | Prevalence of GI at 1-year pp (convert GI) | Diagnostic test at 3-year pp | Prevalence of GI at 3-year pp (convert to GI) |
---|---|---|---|---|---|
Glucose-tolerant participants at 4–12 weeks postpartum who convert to be glucose-intolerant at 1-year or at 3-year postpartum | |||||
 oGTT (n = 791) | 81.8% | FPG & HbA1c | 34.3% | FPG & HbA1c | 35.0% |
 FPG & HbA1c (n = 701) | 72.5% | FPG & HbA1c | 33.6% | FPG & HbA1c | 34.7% |
 FPG alone (n = 840) | 86.8% | FPG & HbA1c | 35.1% | FPG & HbA1c | 34.4% |
 oGTT & HbA1c (n = 671) | 69.3% | FPG & HbA1c | 33.3% | FPG & HbA1c | 35.4% |